Table: Phoenixbio -Q1 group results

PhoenixBio

10/08/2018 07:30

Aug 10 (Reuters)- 
             Phoenixbio Co., Ltd. 
             CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                 3 months ended      3 months ended       Year to 
                Jun 30, 2018        Jun 30, 2017     Mar 31, 2019 
                   LATEST             YEAR-AGO          LATEST    
                   RESULTS             RESULTS         FORECAST   
  Sales            158 mln             123 mln           1.50     
                 (+28.7 pct)         (-63.4 pct)      (+66.0 pct) 
  Operating     loss 171 mln        loss 136 mln        124 mln   
  Recurring     loss 164 mln        loss 138 mln        122 mln   
  Net           loss 165 mln        loss 138 mln        104 mln   
  EPS          loss 56.89 yen      loss 48.03 yen      35.87 yen  
  Ann Div                                NIL              NIL     
  -Q2 div                                NIL              NIL     
  -Q4 div                                NIL              NIL     
  
  NOTE - Phoenixbio Co., Ltd.. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=6190.T